Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/20/2025

Lung Cancer Classification and Characteristics

Non-Small Cell Lung Cancer (NSCLC) Subtypes

  • The European Society for Medical Oncology notes that NSCLC represents more than 80% of all lung cancer cases and is further divided into distinct histological subtypes with different clinical behaviors 1, 3
  • Adenocarcinoma comprises approximately 40% of all lung cancers and is the most common NSCLC subtype, typically presenting as peripheral lesions originating in the bronchioles terminales and respiratory bronchioles, and is more common in never-smokers and women compared to other lung cancer types 1, 3, 2
  • Squamous Cell (Epidermoid) Carcinoma accounts for approximately 30% of lung cancers, generally presents as central/endobronchial lesions, and is histologically characterized by intercellular bridges, keratinization, and keratin pearl formation 1, 3
  • Large Cell Carcinoma represents 5-10% of NSCLC cases 1, 3

Small Cell Lung Cancer (SCLC) Characteristics

  • SCLC represents fewer than 20% of lung cancers but has distinct aggressive characteristics, including a high frequency of metastatic disease at diagnosis, with approximately 66-70% of patients presenting with metastatic disease 1, 4
  • The National Comprehensive Cancer Network notes that nearly all SCLC cases are attributable to cigarette smoking 6, 7
  • SCLC is commonly classified into two clinical stages based on radiation therapy field inclusion, with limited stage typically including TNM stage I-III, and extensive stage including TNM stage IV (metastases) or tumor/nodal volume too extensive for tolerable radiation planning 1, 3

REFERENCES